1. Celgene Pops After Proxy Advisor ISS Recommends Bristol-Myers Investors Approve Buyout

    Celgene Pops After Proxy Advisor ISS Recommends Bristol-Myers Investors Approve Buyout

    Institutional Shareholder Services recommends Bristol-Myers Squibb shareholders vote in favor of its bid to buy Celgene...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Bristol-Myers is deeply undervalued and the recent announcement of the Company's proposed acquisition of Celgene Corporation is poorly conceived and ill-advised.
  3. Topics Mentioned

  4. Authors